natgillin/translations-raw huggingface dataset:
Manic episodes in Bipolar I Disorder: the recommended starting dose for Aripiprazole Sandoz is 15 mg administered on a once-a-day schedule without regard to meals as monotherapy or combination therapy (see section 5.1). 
Manične epizode pri bipolarni motnji I: priporočeni začetni odmerek zdravila Aripiprazol Sandoz je 15 mg enkrat na dan ne glede na obroke hrane, in sicer kot samostojno zdravilo ali v sklopu kombiniranega zdravljenja (glejte poglavje 5.1).
In clinical trials with aripiprazole, there were no significant differences in the incidence rates of hyperglycaemia-related adverse reactions (including diabetes) or in abnormal glycaemia laboratory values compared to placebo. 
Med kliničnimi preskušanji aripiprazola v primerjavi s placebom niso ugotovili značilnih razlik v incidenci hiperglikemičnih neželenih učinkov (vključno s sladkorno boleznijo) ali nenormalnih laboratorijskih vrednosti glukoze v krvi.
The active substance is aripiprazole. 
• Zdravilna učinkovina je aripiprazol.
Aripiprazole Sandoz 5 mg, 10 mg, 15 mg, 30 mg tablets High density polyethylene (HDPE) tablet container (bottle) containing a silica gel desiccant and a polyester coil. 
Aripiprazol Sandoz 5 mg, 10 mg, 15 mg, 30 mg tablete Vsebnik za tablete (plastenka) iz polietilena visoke gostote (HDPE), ki vsebuje silikagelno sušilno sredstvo in poliestrski navoj.
How to store Aripiprazole Sandoz tablets Contents of the pack and other information 
Shranjevanje zdravila Aripiprazol Sandoz Vsebina pakiranja in dodatne informacije
Before treatment with Aripiprazole Sandoz, tell your doctor if you suffer from 
Pred začetkom zdravljenja z zdravilom Aripiprazol Sandoz morate obvestiti zdravnika, če:
What Aripiprazole Sandoz is and what it is used for 
Kaj je zdravilo Aripiprazol Sandoz in za kaj ga uporabljamo
Manic episodes in Bipolar I Disorder: in a 12-week controlled trial, the incidence of EPS was 23.5% for aripiprazole-treated patients and 53.3% for haloperidol-treated patients. 
Manične epizode pri bipolarni motnji I: v 12- tedenskem nadzorovanem preskušanju je bila pojavnost EPS pri bolnikih, ki so se zdravili z aripiprazolom 23,5 %, pri bolnikih, ki so se zdravili s haloperidolom pa 53,3 %.
The 20 mg tablets are supplied in Aluminium//Aluminium blisters packed in cartons containing 14, 28, 49, 56 or 98 tablets. 
Tablete z jakostjo 20 mg so na voljo v škatlah s pretisnimi omoti aluminij/aluminij, ki vsebujejo po 14, 28, 49, 56 ali 98 tablet.
• triptans, tramadol and tryptophan used for conditions including depression, generalised anxiety disorder, 
• triptane, tramadol in triptofan navadno uporabljamo za bolezni, vključno z depresijo,
Aripiprazole Sandoz is not recommended for use in patients with schizophrenia below 15 years of age due to insufficient data on safety and efficacy (see sections 4.8 and 5.1). 
Zaradi nezadostnih podatkov o varnosti in učinkovitosti uporaba zdravila Aripiprazol Sandoz pri bolnikih s shizofrenijo, mlajših od 15 let, ni priporočljiva (glejte poglavji 4.8 in 5.1).
Adolescents aged 13 years and older experienced side effects that were similar in frequency and type to those in adults except that sleepiness, uncontrollable twitching or jerking movements, restlessness, and tiredness were very common (greater than 1 in 10 patients) and upper abdominal pain, dry mouth, increased heart rate, weight gain, increased appetite, muscle twitching, uncontrolled movements of the limbs, and feeling dizzy, especially when getting up from a lying or sitting position, were common (greater than 1 in 100 patients). 
Dodatni neželeni učinki pri otrocih in mladostnikih Neželeni učinki pri mladostnikih, starih 13 let in starejših, so bili po pogostnosti in vrsti podobni neželenim učinkom pri odraslih, z izjemo naslednjih: zaspanost, nenadzorovani trzaji ali nehotni gibi, nemirnost in utrujenost, ki so bili zelo pogosti (prisotni pri več kot 1 od 10 bolnikov), ter bolečina v zgornjem predelu trebuha, suha usta, hiter srčni utrip, povečanje telesne mase, povečan apetit, trzanje mišic, nenadzorovano gibanje udov in omotica, še posebej pri vstajanju iz ležečega ali sedečega položaja, ki so bili pogosti (prisotni pri več kot 1 od 100 bolnikov).
Aripiprazole Sandoz is for oral use. 
Zdravilo Aripiprazol Sandoz je namenjeno za peroralno uporabo.
Aripiprazole Sandoz 5 mg tablets Aripiprazole Sandoz 10 mg tablets Aripiprazole Sandoz 15 mg tablets Aripiprazole Sandoz 20 mg tablets Aripiprazole Sandoz 30 mg tablets aripiprazole 
Aripiprazol Sandoz 5 mg tablete Aripiprazol Sandoz 10 mg tablete Aripiprazol Sandoz 15 mg tablete Aripiprazol Sandoz 20 mg tablete Aripiprazol Sandoz 30 mg tablete aripiprazol
Rīga, LV1010 
K.Valdemāra iela 33-30 Rīga, LV1010
Manic episodes in Bipolar I Disorder in adolescents aged 13 years and older The frequency and type of adverse reactions in adolescents with Bipolar I Disorder were similar to those in adults except for the following reactions: very commonly (≥ 1/10) somnolence (23.0%), extrapyramidal disorder (18.4%), akathisia (16.0%), and fatigue (11.8%); and commonly (≥ 1/100, < 1/10) abdominal pain upper, heart rate increased, weight increased, increased appetite, muscle twitching, and dyskinesia. 
Manične epizode pri bipolarni motnji I pri mladostnikih, starih 13 let in več Pri mladostnikih z bipolarno motnjo I so bili neželeni učinki po pogostnosti in vrsti podobni kot pri odraslih, z izjemo naslednjih: somnolence (23,0 %), ekstrapiramidnih motenj (18,4 %), akatizije (16,0 %) in utrujenosti (11,8 %), ki so bili zelo pogosti (≥ 1/10), ter bolečine v zgornjem predelu trebuha, hitrejšega srčnega utripa, povečanja telesne mase, povečanega apetita, trzanja mišic in diskinezije, ki so bili pogosti (≥ 1/100, < 1/10).
• antidepressants or herbal remedy used to treat depression and anxiety (such as fluoxetine, paroxetine, 
• antidepresive ali pripravke rastlinskega izvora proti depresiji in tesnobnosti (kot so fluoksetin,
Aripiprazole group showed animprovement of 14.97 on TTS-YGTSS change from baseline to week 10 as compared with an improvement of 9.62 in the placebo group. 
teden vidno izboljšanje za 14,97 točk po lestvici TTS-YGTSS od izhodiščne vrednosti, v primerjavi z izboljšanjem za 9,62 točke pri skupini, ki je prejemala placebo.
In placebo-controlled trials, the incidence of akathisia in bipolar patients was 12.1% with aripiprazole and 3.2% with placebo. 
V s placebom nadzorovanih preskušanjih je bila pojavnost akatizije pri bolnikih z bipolarno motnjo pri uporabi aripiprazola 12,1 %, pri uporabi placeba pa 3,2 %.
In another 12-week trial, the incidence of EPS was 26.6% for patients treated with aripiprazole and 17.6% for those treated with lithium. 
V drugem 12- tedenskem preskušanju je bila pojavnost EPS pri bolnikih, ki so se zdravili z aripiprazolom 26,6 %, pri bolnikih, ki so se zdravili z litijem pa 17,6 %.
A single-dose study in subjects with varying degrees of liver cirrhosis (Child-Pugh Classes A, B, and C) did not reveal a significant effect of hepatic impairment on the pharmacokinetics of aripiprazole and dehydroaripiprazole, but the study included only 3 patients with Class C liver cirrhosis, which is insufficient to draw conclusions on their metabolic capacity. 
Raziskava z enim samim odmerkom pri preiskovancih z različno stopnjo jetrne ciroze (razredi A, B in C po Child-Pughu) ni pokazala pomembnega učinka okvare jeter na farmakokinetiko aripiprazola in dehidroaripiprazola.
Manic episodes in Bipolar I Disorder in adolescents aged 13 years and older: the recommended dose for Aripiprazole Sandoz is 10 mg/day administered on a once-a-day schedule without regard to meals. 
Manične epizode pri bipolarni motnji I pri mladostnikih, starih 13 let in več: priporočeni odmerek zdravila Aripiprazol Sandoz je 10 mg enkrat na dan ne glede na obrok hrane.
Overall, 1.3% of aripiprazoletreated patients reported cerebrovascular adverse reactions compared with 0.6% of placebo-treated patients in these trials. 
V celoti so v teh preskušanjih cerebrovaskularne neželene učinke zabeležili pri 1,3 % bolnikov, zdravljenih z aripiprazolom, in pri 0,6 % bolnikov, ki so dobivali placebo.
Despite the high comorbidity frequency of Bipolar I Disorder and ADHD, very limited safety data are available on concomitant use of aripiprazole and stimulants; therefore, extreme caution should be taken when these medicinal products are co-administered. 
Kljub pogosti sočasni obolevnosti za bipolarno motnjo I in motnjo pomankanja pozornosti je na voljo zelo malo podatkov o sočasni uporabi aripiprazola in stimulansov.
Manic episodes in Bipolar I Disorder in children and adolescents Aripiprazole was studied in a 30-week placebo-controlled trial involving 296 children and adolescents (1017 years), who met DSM-IV criteria for Bipolar I Disorder with manic or mixed episodes with or without psychotic features and had a Y-MRS score ≥ 20 at baseline. 
Manične epizode pri bipolarni motnji I pri otrocih in mladostnikih Uporabo aripiprazola so raziskovali v 30-tedenskem s placebom nadzorovanem preskušanju, ki je vključevalo 296 otrok in mladostnikov (10-17 let), ki so ustrezali kriterijem DSM-IV za bipolarno motnjo I z maničnimi ali mešanimi epizodami s psihotičnimi lastnostmi ali brez njih, in so imeli v izhodišču oceno ≥ 20 po lestvici Y-MRS. Izmed bolnikov, ki so bili vključeni v primarno analizo učinkovitosti, je imelo 139 bolnikov sočasno tudi diagnozo motnje pomanjkanja pozornosti s hiperaktivnostjo (ADHD - Attention deficit hyperactivity disorder).
Schizophrenia in adolescents aged 15 years and older: the recommended dose for Aripiprazole Sandoz is 10 mg/day administered on a once-a-day schedule without regard to meals. 
Shizofrenija pri mladostnikih, starih 15 let in več: priporočeni odmerek zdravila Aripiprazol Sandoz je 10 mg enkrat na dan ne glede na obroke hrane.
UNIQUE IDENTIFIER - 2D BARCODE [Only Carton for bottle:] 
EDINSTVENA OZNAKA - DVODIMENZIONALNA ČRTNA KODA [Samo za zunanjo ovojnino plastenke:] Vsebuje dvodimenzionalno črtno kodo z edinstveno oznako.
Sandoz d..d Pārstāvniecība Latvijā K.Valdemāra iela 33-30 
Latvija Sandoz d..d Pārstāvniecība Latvijā
In the long term 26-week maintenance phase of a placebo-controlled trial, the incidence of EPS was 18.2% for aripiprazole-treated patients and 15.7% for placebo-treated patients. 
V dolgotrajni 26-tedenski vzdrževalni fazi s placebom nadzorovanega preskušanja je bila pojavnost EPS pri bolnikih, ki so se zdravili z aripiprazolom 18,2 %, pri bolnikih, ki so prejemali placebo pa 15,7 %.
18 years and presented an average score of 29 on TTS-YGTSS at baseline. 
Bolniki so bili stari od 6 do 18 let, njihov povprečni izhodiščni rezultat na lestvici TTS-YGTSS pa je bil 29.
These medicines may increase the risk of side effects; if you get any unusual symptom taking any of these medicines together with Aripiprazole Sandoz, you should see your doctor. 
Če opazite kakršen koli neobičajen simptom ob jemanju katerega od teh zdravil skupaj z zdravilom Aripiprazol Sandoz, obiščite zdravnika.
It may harm them, even iftheirsignsof illnessarethesameasyours. 
Njim bi lahko celo škodovalo, čeprav imajo znake bolezni, podobne vašim.
In another long-term 26-week controlled trial, the incidence of EPS was 14.8% for aripiprazole-treated patients and 15.1% for olanzapinetreated patients. 
V drugem dolgoročnem 26-tedenskem nadzorovanem preskušanju je bila incidenca EPS pri bolnikih, zdravljenih z aripiprazolom, 14,8 % in pri bolnikih, zdravljenih z olanzapinom, 15,1 %.
Patients were 6 
Starejši bolniki
How to take Aripiprazole Sandoz 
Kako jemati zdravilo Aripiprazol Sandoz
Excipient(s) with known effect 132.33 mg lactose monohydrate per tablet. 
Pomožna(e) snov(i) z znanim učinkom 132,33 mg laktoze monohidrat na tableto
Aripiprazole Sandoz 20 mg tablets EU/1/15/1029/043 (14 tablets) EU/1/15/1029/044 (28 tablets) EU/1/15/1029/045 (49 tablets) EU/1/15/1029/046 (56 tablets) EU/1/15/1029/047 (98 tablets) 
Aripiprazol Sandoz 20 mg tablete EU/1/15/1029/043 (14 tablet) EU/1/15/1029/044 (28 tablet) EU/1/15/1029/045 (49 tablet) EU/1/15/1029/046 (56 tablet) EU/1/15/1029/047 (98 tablet)
EU/1/15/1029/043 14 tablets EU/1/15/1029/044 28 tablets EU/1/15/1029/045 49 tablets EU/1/15/1029/046 56 tablets EU/1/15/1029/047 98 tablets 
EU/1/15/1029/043 14 tablet EU/1/15/1029/044 28 tablet EU/1/15/1029/045 49 tablet EU/1/15/1029/046 56 tablet EU/1/15/1029/047 98 tablet
venlafaxine, St. John's Wort) 
paroksetin, venlafaksin, šentjanževka),
In two long term trials with adolescent (13-17 years) schizophrenia and bipolar patients treated with aripiprazole, incidence of low serum prolactin levels in females (<3 ng/ml) and males (<2 ng/ml) was 37.0 % and 59.4 %, respectively. 
Pri dveh dolgotrajnih preskušanjih pri mladostnikih (starosti od 13 do 17 let) s shizofrenijo in bipolarno motnjo, ki so se zdravili z aripiprazolom, je bila pojavnost nizkih vrednosti prolaktina v serumu pri ženskah 37,0 % (< 3 ng/ml) in pri moških (< 2 ng/ml) 59,4 %.
Aripiprazole Sandoz is indicated for the treatment up to 12 weeks of moderate to severe manic episodes in Bipolar I Disorder in adolescents aged 13 years and older (see section 5.1). 
Zdravilo Aripiprazol Sandoz je indicirano za zdravljenje zmernih do hudih maničnih epizod pri bipolarni motnji I pri mladostnikih, starih 13 let in več.
Aripiprazole Sandoz contains lactose 
Zdravilo Aripiprazol Sandoz vsebuje laktozo
Tics associated with Tourette's disorder in paediatric patients (see section 4.2) The efficacy of aripiprazole was studied in paediatric subjects with Tourette's disorder (aripiprazole: n=99, placebo: n=44) in a randomised, double-blind, placebo controlled, 8 week study using a fixed dose weightbased treatment group design over the dose range of 5 mg/day to 20 mg/day and a starting dose of 2 mg. 
Tiki, povezani s Tourettovim sindromom, pri pediatričnih bolnikih (glejte poglavje 4.2) Učinkovitost aripiprazola je bila raziskana pri pediatrični populaciji s Tourettovo motnjo (aripiprazol: n = 99, placebo: n = 44) v 8-tedenski randomizirani, dvojno slepi, s placebom nadzorovani študiji, zasnovani z zdravljenimi skupinami, ki so prejemale nespremenjen odmerek glede na telesno maso posameznika v razponu od 5 mg/dan do 20 mg/dan, z začetnim odmerkom 2 mg. Bolniki so bili stari od 7 do 17 let, povprečni izhodiščni rezultat njihovega števila tikov po skupni oceni resnosti tikov na lestvici TTS-YYGTSS (angl. Total Tic Severity Score - Yale Global Tic Severity Scale) pa je bil 30.
What Aripiprazole Sandoz tablets look like and contents of the pack´ 
Izgled zdravila Aripiprazol Sandoz in vsebina pakiranja
Excipient(s) with known effect 71.02 mg lactose monohydrate per tablet. 
Pomožna(e) snov(i) z znanim učinkom 71,02 mg laktoze monohidrat na tableto
In the adolescent (13-17 years) schizophrenia population with aripiprazole exposure of 5 to 30 mg up to 72 months, incidence of low serum prolactin levels in females (<3 ng/ml) and males (<2 ng/ml) was 25.6% and 45.0%, respectively. 
Pri populaciji mladostnikov (starosti od 13 do 17 let) s shizofrenijo, ki so največ 72 mesecev izpostavljeni apriprazolu 5 do 30 mg, je bila pojavnost nizkih vrednosti prolaktina v serumu pri ženskah (< 3 ng/ml) 25,6 % in pri moških (< 2 ng/ml) 45,0 %.
Aripiprazole Sandoz 20 mg tablets Each tablet contains 20 mg aripiprazole. 
Aripiprazol Sandoz 20 mg tablete Ena tableta vsebuje 20 mg aripiprazola.
Suicide attempt, suicidal ideation and completed suicide (see section 4.4) 
Psihiatrične motnje nespečnost anksioznost nemir depresija hiperseksualnost poskus samomora, misli na samomor in samomor (glejte poglavje 4.4) patološko hazardiranje
Blister packs in cartons: 14, 28, 49, 56, 98 tablets 
Aripiprazol Sandoz 20 mg tabletePretisni omoti v škatlah: 14, 28, 49, 56, 98 tablet
• diarrhoea, 
sladkorna bolezen,
Excipient(s) with known effect 196.50 mg lactose monohydrate per tablet. 
Pomožna(e) snov(i) z znanim učinkom 196,50 mg laktoze monohidrat na tableto
Aripiprazole Sandoz 30 mg tablets Each tablet contains 30 mg aripiprazole. 
Aripiprazol Sandoz 30 mg tablete Ena tableta vsebuje 30 mg aripiprazola.
Excipient(s) with known effect 97.75 mg lactose monohydrate per tablet. 
Pomožna(e) snov(i) z znanim učinkom 97,75 mg laktoze monohidrat na tableto
In the pooled adolescent schizophrenia population (13-17 years) with exposure up to 2 years, incidence of low serum prolactin levels in females (<3 ng/ml) and males (<2 ng/ml) was 29.5% and 48.3%, respectively. 
V populaciji mladostnikov s shizofrenijo (13-17 let), ki so se zdravili do 2 leti, je bila pogostnost nizke ravni prolaktina v serumu pri ženskah (< 3 ng/ml) 29,5 % in pri moških (< 2 ng/ml) 48,3 %.
Aripiprazole Sandoz20mg tablets are white coloured, round shaped tablets, with an approximate diameter of 7.8mm, debossed with “SZ” on one side and “448” on the other side. 
Tablete Aripiprazol Sandoz 20 mg so bele okrogle tablete s približnim premerom 7,8 mm, z vtisnjeno oznako “SZ” na eni strani in “448” na drugi strani.
In a 26- week, olanzapine-controlled, double-blind, multi-national study of schizophrenia which included 314 adult patients and where the primary end-point was weight gain, significantly less patients had at least 7% weight gain over baseline (i.e. a gain of at least 5.6 kg for a mean baseline weight of ~80.5 kg) on aripiprazole (n= 18, or 13% of evaluable patients), compared to olanzapine (n= 45, or 33% of evaluable patients). 
za vsaj 5,6 kg pri povprečni izhodiščni masi ~ 80,5 kg) značilno redkejše pri bolnikih, ki so dobivali aripiprazol, (n = 18 ali 13 % ocenljivih bolnikov) kot pri tistih, ki so dobivali olanzapin (n = 45 ali 33 % ocenljivih bolnikov).
In a short-term placebo-controlled clinical trial involving 302 adolescents (13-17 years) with schizophrenia, the frequency and type of adverse reactions were similar to those in adults except for the following reactions that were reported more frequently in adolescents receiving aripiprazole than in adults receiving aripiprazole (and more frequently than placebo): 
V kratkotrajnem, s placebom nadzorovanem kliničnem preskušanju, ki je vključevalo 302 mladostnika (13-17 let) s shizofrenijo, so bili neželeni učinki po pogostnosti in vrsti podobni kot pri odraslih, z izjemo naslednjih neželenih učinkov, ki so bili pri mladostnikih, ki so prejemali aripiprazol, pogostejši kot pri odraslih, ki so prejemali aripiprazol (in pogostejši kot pri placebu): somnolenca/sedacija in ekstrapiramidne motnje so bili zelo pogosti (≥ 1/10), suha usta, povečan apetit in ortostatska hipotenzija pa pogosti (≥ 1/100, < 1/10) neželeni učinki.
Each tablet contains 20 mg of aripiprazole. 
Ena tableta vsebuje 20 mg aripiprazola.
Excipient(s) with known effect 65.97 mg lactose monohydrate per tablet. 
Pomožna(e) snov(i) z znanim učinkom 65,97 mg laktoze monohidrat na tableto
Pathological gambling Impulse-control disorders Binge eating 
Neznana pogostnost motnje nadzora impulzov kompulzivno prenajedanje kompulzivno nakupovanje poriomanija agresija agitacija živčnost
Musculoskeletal and connective tissue disorders 
Neznana pogostnost in vezivnega tkiva togost
The other ingredients are lactose monohydrate, maize starch, microcrystalline cellulose, hydroxypropyl cellulose, magnesium stearate, red iron oxide (E172). 
• Druge sestavine zdravila so laktoza monohidrat, koruzni škrob, mikrokristalna celuloza, hidroksipropilceluloza, magnezijev stearat, rdeči železov oksid (E172).
The other ingredients are lactose monohydrate, maize starch, microcrystalline cellulose, hydroxypropyl cellulose, magnesium stearate, indigo carmine (E132) aluminium lake. 
• Druge sestavine zdravila so laktoza monohidrat, koruzni škrob, mikrokristalna celuloza, hidroksipropilceluloza, magnezijev stearat, indigotin (E132).
White coloured, round shaped tablet, with an approximate diameter of 7.8 mm, debossed with “SZ” on one side and “448” on the other side. 
Bele, okrogle, tablete s približnim premerom 7,8 mm, z vtisnjeno oznako “SZ” na eni strani in “448” na drugi strani.
Rhabdomyolysis Myalgia Stiffness 
Bolezni mišičnoskeletnega sistema rabdomioliza mialgija
Blue coloured, mottled, round shaped tablet, with an approximate diameter of 6.0 mm, debossed with “SZ” on one side and “444” on the other side. 
Modre, lisaste, okrogle tablete s približnim premerom 6,0 mm, z vtisnjeno oznako “SZ” na eni strani in “444” na drugi strani.
Aripiprazole Sandoz 5 mg tablets Each tablet contains 5 mg aripiprazole. 
Aripiprazol Sandoz 5 mg tablete Ena tableta vsebuje 5 mg aripiprazola.
Yellow coloured, mottled, round shaped tablet, with an approximate diameter of 7.0 mm, debossed with “SZ” on one side and “447” on the other side. 
Rumene, lisaste, okrogle tablete s približnim premerom 7,0 mm, z vtisnjeno oznako “SZ” na eni strani in “447” na drugi strani.
OUTER CARTON FOR BOTTLE AND LABEL FOR BOTTLE 
PODATKI NA ZUNANJI OVOJNINI IN PRIMARNI OVOJNINI ZUNANJA OVOJNINA ZA PLASTENKO IN NALEPKA ZA PLASTENKO
Pink coloured, mottled, round shaped tablet, with an approximate diameter of 9.0 mm, debossed with “SZ” on one side and “449” on the other side. 
Rožnate, lisaste, okrogle tablete s približnim premerom 9,0 mm, z vtisnjeno oznako “SZ” na eni strani in “449” na drugi strani.
Aripiprazole Sandoz30mg tablets are pink coloured, mottled, round shaped tablets, with an approximate diameter of 9.0mm, debossed with “SZ” on one side and “449” on the other side. 
Tablete Aripiprazol Sandoz 30 mg so rožnate lisaste okrogle tablete s približnim premerom 9,0 mm, z vtisnjeno oznako “SZ” na eni strani in “449” na drugi strani.
Aripiprazole Sandoz 5 mg tablets are blue coloured, mottled, round shaped tablets, with an approximate diameter of 6.0 mm, debossed with “SZ” on one side and “444” on the other side. 
Tablete Aripiprazol Sandoz 5 mg so modre lisaste okrogle tablete s približnim premerom 6,0 mm, z vtisnjeno oznako “SZ” na eni strani na eni strani in “444” na drugi strani.
Aripiprazole Sandoz15mg tablets are yellow coloured, mottled, round shaped tablets, with an approximate diameter of 7.0mm, debossed with “SZ” on one side and “447” on the other side. 
Tablete Aripiprazol Sandoz 15 mg so rumene lisaste okrogle tablete s približnim premerom 7,0 mm, z vtisnjeno oznako “SZ” na eni strani in “447” na drugi strani.
In the paediatric bipolar population (10-17 years) with exposure up to 30 weeks, incidence of low serum prolactin levels in females (<3 ng/ml) and males (<2 ng/ml) was 28.0% and 53.3%, respectively. 
V pediatrični populaciji z bipolarno motnjo (10-17 let), ki so se zdravili do 30 tednov, je bila pogostnost nizke ravni prolaktina v serumu pri deklicah (< 3 ng/ml) 28,0 %, pri dečkih (< 2 ng/ml) pa
Aripiprazole Sandoz 15 mg tablets Each tablet contains 15 mg aripiprazole. 
Aripiprazol Sandoz 15 mg tablete Ena tableta vsebuje 15 mg aripiprazola.
• seizure, 
Pri odmerkih,
Pink coloured, mottled, round shaped tablet, with an approximate diameter of 6.0 mm, debossed with “SZ” on one side and “446” on the other side. 
Rožnate, lisaste, okrogle tablete s približnim premerom 6,0 mm, z vtisnjeno oznako “SZ” na eni strani in “446” na drugi strani.
Renal impairment 
Jeterna okvara
The other ingredients are lactose monohydrate, maize starch, microcrystalline cellulose, hydroxypropyl cellulose, magnesium stearate, yellow iron oxide. 
• Druge sestavine zdravila so laktoza monohidrat, koruzni škrob, mikrokristalna celuloza, hidroksipropilceluloza, magnezijev stearat, rumen železov oksid.
These medicines may increase the risk of side effects or reduce the effect of Aripiprazole Sandoz; if you get any unusual symptom taking any of these medicines together with Aripiprazole Sandoz you should see your doctor. 
Ta zdravila lahko povečajo tveganje za neželene učinke ali zmanjšajo učinek zdravila Aripiprazol Sandoz.
Aripiprazole Sandoz 10 mg tablets Each tablet contains 10 mg aripiprazole. 
Aripiprazol Sandoz 10 mg tablete Ena tableta vsebuje 10 mg aripiprazola.
Aripiprazole Sandoz 30 mg tablets 
Aripiprazol Sandoz 30 mg tablete
Hypersensitivity reactions, characterised by allergic symptoms, may occur with aripiprazole (see section 
Tudi pri aripiprazolu se lahko pojavijo preobčutljivostne reakcije v obliki simptomov alergije (glejte poglavje 4.8).